Author:
Alibakhshi Tuba,Khodayar Mohammad Javad,Khorsandi Layasadat,Rashno Mohammad,Zeidooni Leila
Funder
Toxicology Research Center
Vice Chancellor of Research, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Subject
Pharmacology,General Medicine
Reference63 articles.
1. Cisplatin-induced kidney dysfunction and perspectives on improving treatment strategies;Oh;Electrolytes Blood Press,2014
2. Inhibition of telomerase activity by cisplatin in human testicular cancer cells;Burger;Eur. J. Cancer,1997
3. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study;von der Maase;J. Clin. Oncol.,2000
4. Intraperitoneal cisplatin and paclitaxel in ovarian cancer;Armstrong;N. Engl. J. Med.,2006
5. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial;Mitsudomi;Lancet Oncol.,2010
Cited by
58 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献